ArticleFrontiers in pediatrics2026
Temporal and anatomic determinants of central-line-associated bloodstream infection risk in a tertiary PICU: a 3-year time-to-event and competing-risk analysis.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Central line-associated bloodstream infections remain a major cause of preventable morbidity in pediatric intensive care units, yet most prevention strategies treat infection risk as static over catheter dwell time. Objective: We aimed to characterize the temporal and anatomic determinants of central line-associated bloodstream infection in a tertiary pediatric intensive care unit using patient-day survival data. Methods: In this retrospective cohort study, 300 central venous catheter insertions in children admitted to a tertiary pediatric intensive care unit between January 2020 and December 2022 were screened for eligibility. The daily risk of first central line-associated bloodstream infection was modelled using discrete-time pooled-logistic regression with ridge regularization, incorporating baseline covariates, catheter dwell time (0-14, 15-22, and ≥23 days), time-varying clinical markers lagged by 24 hours, and catheter insertion site (femoral, internal jugular, subclavian). Fine-Gray subdistribution hazard models accounted for competing events (catheter removal, discharge, or death). Model performance was evaluated using bootstrap-corrected Harrell's C-index and calibration plots. Results: After exclusions, 270 non-tunneled central venous catheters contributed 4,304 catheter-days. Over 4,304 catheter-days, 13 central line-associated bloodstream infections occurred (incidence 3.0 per 1,000 catheter-days). Compared with dwell time less than 14 days, adjusted odds of infection were 4.33 (95% CI 1.89-9.92) for days 15-22 and 11.71 (95% CI 3.22-42.62) for dwell time of 23 days or more. Right internal jugular insertion was associated with lower adjusted odds relative to femoral access (adjusted odds ratio 0.34; 95% CI 0.14-0.81). Fever in the preceding 24 hours was associated with a threefold higher odds of infection (adjusted odds ratio 3.00; 95% CI 0.94-9.52). The model demonstrated good discrimination (bias-corrected C-index 0.78; 95% CI 0.70-0.86) and acceptable calibration. Conclusion: In this tertiary pediatric intensive care unit, central line-associated bloodstream infection risk was strongly phase-dependent, rising sharply after the second week of catheter dwell and particularly beyond 23 days, and was lower with right internal jugular than femoral insertion. These temporal and anatomic findings support time-triggered line-necessity reviews and careful consideration of insertion site within the broader clinical context when seeking to reduce infection risk in critically ill children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.